Repeat Mid-Urethral Sling in Management of Recurrent or Persistent Stress Urinary Incontinence
Xian-Hui Liu,Hao Hu,Wei-Yu Zhang,Huan-Rui Wang,Qi Wang,Ke-Xin Xu
DOI: https://doi.org/10.1097/cm9.0000000000000635
IF: 6.133
2020-01-01
Chinese Medical Journal
Abstract:According to the International Continence Society, stress urinary incontinence (SUI) was defined as involuntary leakage on effort or exertion, or on sneezing or coughing. The prevalence of SUI varies among different age groups and is reportedly 48% (29%–75%).[1] The mid-urethral sling (MUS) procedure is currently considered the gold standard in the surgical treatment of SUI. The long-term cure rate of SUI using MUS ranges from 76.9% to 90.0%.[1,2] However, incontinence persists in approximately 20% of SUI patients who underwent MUS procedure, and they require further treatment. Persistent SUI was defined as early leakage due to increased intra-abdominal pressure induced by stress events occurring within 6 weeks of the first MUS procedure, whereas recurrent SUI was defined as later leakage occurring more than 6 weeks after the first MUS. Previous studies report that repeat MUSs can achieve outcomes similar to that of initial MUSs.[2,3] However, related studies in the Chinese population were rare. In this retrospective study, we evaluate the efficacy of repeat MUSs based on the degree of improvement of leakage of urine and assess the safety of the procedure based on the incidence of intra-operative and post-operative complications. This study was approved by the Ethical Committee of Peking University People's Hospital, and waiver of patient informed consent was approved. Between January 2010 and January 2017, twenty patients with persistent SUI or recurrent SUI underwent repeat MUS procedures in our center. Patients lost to follow-up and patients with concomitant urgent urinary incontinence or pelvic organ prolapse were excluded. A total of 17 patients were included in this retrospective study. Tension-free vaginal tape (TVT) was performed in 14 cases and trans-obturator tape (TOT) in three cases. Pre-operative assessment for repeat MUS included detailed medical history taking, physical examination, voiding diary for 2 to 3 days, urinalysis, urine culture, and multi-channel urodynamic study including uroflowmetry, post-void residual urine measurement, filling and voiding cystometry, and abdominal leakage point pressure (ALPP) measurement. Repeat MUSs were performed under spinal anesthesia by the same experienced surgeon. Patients were discharged on the day following the surgery in the absence of urinary retention, unbearable pain in the thigh, or other complications. All patients were followed up for 12 to 80 months after the repeat MUS procedures. Subjective cure was defined as the absence of involuntary urine leakage during stressful activities as reported by the patients, and improvement was defined as a significant decrease in urine leakage; other outcomes were regarded as failure. A total of 17 patients underwent repeat MUSs due to persistent SUI (6/17) or recurrent SUI (11/17). The clinical characteristics, outcomes, and complications observed in patients are presented in Table 1. The initial MUS procedures were TOT in 14 cases and TVT in three cases, whereas the repeat MUS procedures were TVT in 14 cases and TOT in three cases. No significant bleeding or bladder perforation occurred intra-operatively, and all 17 patients were able to void after removing the urethral catheter. At a mean follow-up of 37.9 months (range 12–80 months), cure was achieved in 10/17 of patients, improvement in 2/17, and failure in 5/17 patients. De novo urgency after repeat MUS occurred in two patients. There was no occurrence of vaginal erosion, recurrent urinary tract infection, or prolonged urinary retention.Table 1: Clinical characteristics of patients with repeat mid-urethral sling, n = 17.The MUSs were developed to support the mid-urethra for reducing hypermobility based on the “hammock hypothesis” described by DeLancey.[4] The MUSs can reportedly achieve high long-term cure rate and are first-line treatments for SUI in women.[1,2] Unfortunately, incontinence persists in approximately 20% of patients who then require further treatments, which is frustrating for both patients and surgeons. The widely accepted possible reasons for MUS failures include inappropriate fixation of the sub-urethral tape and the underlying pathology of the urinary incontinence mechanism [3]. In this study, one patient had the initial tape cut due to extreme voiding difficulty because of too much tension on the tape 1 week after the initial surgery, which led to the recurrence of SUI. There are studies reporting that patients with intrinsic sphincter deficiency (ISD) have higher risks of failure than those with solely urethral hypermobility due to the pathology of the urinary incontinence mechanism.[2] In 11 cases with detailed information of urodynamic study, six patients belonged to SUI type III category (ISD, ALPP ≤60, 1 cmH2O = 0.098 kPa) and two patients belonged to type II category (60 cmH2O